Friday, November 09, 2007

Merck Agrees to Settle Vioxx cases

After spending millions in legal fees, Merck sees the light, or at least the bottom line, and agrees to settle pending Vioxx lawsuits.
The pharmaceutical giant Merck reverses its course and agrees to settle Vioxx lawsuits. Merck will pay nearly $5 billion to settle nearly 27,000 pending lawsuits. Up until this time, the company's policy was to fight each suit individually, a strategy it was winning. But after spending an estimated $600 million a year in legal fees, Merck suits must have realized it wouldn't take long to exceed the settlement amount. Of course the real winners will be the lawyers. What else is new?